MYLAN LABS LTD Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN LABS LTD, and what generic and branded alternatives to MYLAN LABS LTD drugs are available?
MYLAN LABS LTD has one hundred and fifteen approved drugs.
There are nine tentative approvals on MYLAN LABS LTD drugs.
Drugs and US Patents for MYLAN LABS LTD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Labs Ltd | VANCOMYCIN HYDROCHLORIDE | vancomycin hydrochloride | POWDER;INTRAVENOUS | 209481-003 | Jul 10, 2018 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Labs Ltd | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 205242-001 | Dec 6, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Mylan Labs Ltd | STAVUDINE | stavudine | CAPSULE;ORAL | 078775-002 | Jan 5, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.